Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
314.7 USD | -1.35% | +0.59% | +9.27% |
05-16 | Amgen Gets FDA Approval for Small-Cell Lung-Cancer Treatment | DJ |
05-16 | Amgen's Imdelltra Gets US FDA Accelerated Approval for Drug to Treat Extensive Stage Small Cell Lung Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.27% | 169B | |
+32.36% | 694B | |
+29.91% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.64% | 239B | |
+10.55% | 209B | |
-2.86% | 209B | |
+0.45% | 164B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- FDA Adds 'Boxed Warning' for Hypocalcemia Risk to Amgen's Osteoporosis Drug Prolia